Medtronic
ProfileJobs (2.19 k)

Medtronic

Suggest Edit
    • HealthcareManufacturing & Industrialimagingmedical devicesmedtechsurgical solutions
    Medtronic manufactures and sells device-based medical therapies. Its products include pacemakers, insertable cardiac monitors, implantable defibrillators, leads and delivery systems, ablation products, electrophysiology catheters, coronary and peripheral stents and related delivery systems, therapies for uncontrolled hypertension, endovascular stent graft systems, heart valve replacement technologies, and cardiac tissue ablation systems. The Company also manufactures image-guided surgery and intra-operative imaging systems.
    Revenue(FY, 2018)
    $30 B
    Market capitalization(2019-01-17)
    $117.7 B
    Patients(FY, 2016)
    65 M

    Employee Rating

    3.6More
    TypePublic
    HQMinneapolis, US
    Founded1949
    Size (employees)86,000 (est)
    Websitemedtronic.com
    Medtronic was founded in 1949 and is headquartered in Minneapolis, US
    Report incorrect company information

    Viewing summary data as a guest

    Sign up for free to see all data

    Key People/Management at Medtronic

    Omar Ishrak

    Omar Ishrak

    CEO, Chairman
    Karen Parkhill

    Karen Parkhill

    EVP, CFO
    Richard Kuntz

    Richard Kuntz

    SVP, Chief Medical and Scientific Officer
    Carol Surface

    Carol Surface

    SVP and Chief Human Resources Officer
    Show more

    Medtronic Office Locations

    Medtronic has offices in Minneapolis, Doral, Tempe, Tampa and in 83 other locations
    Minneapolis, US (HQ)
    710 Medtronic Parkway
    Doral, US
    450 9850 NW 41st St
    Doral, US
    9850 NW 41st Street, Suite 450
    Miami, US
    Doral Corporate Centre II, 3750 NW 87th Avenue, Suite 700
    Plymouth, US
    3800 Annapolis Ln N #175
    Portsmouth, US
    180 International Dr
    Show all (95)
    Report incorrect company information

    Medtronic Financials and Metrics

    Medtronic Revenue

    Embed Graph
    View revenue for all periods
    Medtronic's revenue was reported to be $29.95 b in FY, 2018 which is a 0.8% increase from the previous period.
    USD

    Revenue (Q2, 2019)

    		7.5b

    Gross profit (Q2, 2019)

    		5.3b

    Gross profit margin (Q2, 2019), %

    		70.6%

    Net income (Q2, 2019)

    		1.1b

    EBIT (Q2, 2019)

    		1.5b

    Market capitalization (17-Jan-2019)

    		117.7b

    Closing stock price (17-Jan-2019)

    		87.6

    Cash (26-Oct-2018)

    		3.9b

    EV

    		137.4b
    Medtronic's current market capitalization is $117.7 b.
    Annual
    USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

    Revenue

    		17.0b20.3b28.8b29.7b30.0b

    Revenue growth, %

    		19%42%3%1%

    Cost of goods sold

    		4.3b6.3b9.1b9.3b9.1b

    Gross profit

    		12.7b14.0b19.7b20.4b20.9b
    Quarterly
    USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

    Revenue

    		7.3b7.1b6.9b7.2b7.3b7.3b7.4b7.1b21.8b7.4b7.5b

    Cost of goods sold

    		2.5b2.2b2.1b2.3b2.3b2.3b2.3b2.1b6.7b2.2b2.2b

    Gross profit

    		4.8b4.9b4.8b4.9b5.0b5.0b5.0b4.9b15.1b5.2b5.3b

    Gross profit Margin, %

    		66%69%69%68%68%69%68%70%69%70%71%
    show all
    Annual
    USDY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

    Cash

    		13.2m4.8b186.4m5.0b3.7b

    Accounts Receivable

    		17.1m5.6b6.0b

    Inventories

    		1.7b3.5b3.5b3.3b3.6b

    Current Assets

    		21.2b30.8b23.6b24.9b23.0b
    Quarterly
    USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

    Cash

    		46.0k3.0b2.4b2.7b3.1b3.0b2.8b4.7b5.5b6.4b4.4b3.9b

    Accounts Receivable

    		(68.0m)

    Inventories

    		3.4b3.5b3.5b3.6b3.7b3.7b3.5b3.8b3.7b3.8b

    Current Assets

    		46.0k29.1b28.7b27.6b23.5b22.5b22.4b24.8b25.2b26.6b22.5b21.7b
    show all
    Annual
    USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

    Net Income

    		3.1b2.7b3.5b4.0b3.1b

    Depreciation and Amortization

    		349.0m1.3b2.8b2.0b2.6b

    Inventories

    		(39.0m)(282.0m)(186.0m)(227.0m)(192.0m)

    Accounts Payable

    Quarterly
    USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

    Net Income

    		(37.1m)820.0m1.3b2.4b929.0m2.0b2.9b1.0b3.0b1.6b1.1b2.2b

    Depreciation and Amortization

    		701.0m1.4b2.1b737.0m1.5b2.2b636.0m1.3b2.0b666.0m1.3b

    Inventories

    		(207.0m)(326.0m)(388.0m)(101.0m)(187.0m)(261.0m)(273.0m)(318.0m)(180.0m)(312.0m)

    Accounts Payable

    		1.3b1.4b1.4b(307.0m)13.0m85.0m24.0m
    show all
    USDY, 2018

    EV/EBIT

    		89 x

    EV/CFO

    		48 x

    Financial Leverage

    		1.8 x
    Show all financial metrics

    Medtronic Operating Metrics

    Medtronic's Patients was reported to be 65 m in FY, 2016.
    FY, 2014FY, 2015FY, 2016

    Countries

    		160 160

    Patents Issued

    		27 k53 k45 k

    Patients

    		65 m
    Show all operating metrics

    Medtronic Acquisitions / Subsidiaries

    Acquired CompanyDateDeal Size
    NutrinoNovember 30, 2018
    Mazor RoboticsSeptember 21, 2018$1.64 b
    Visionsense LtdApril 11, 2018$75 m

    Medtronic Revenue Breakdown

    Embed Graph

    Medtronic revenue breakdown by business segment: 7.1% from Diabetes Group, 25.9% from Restorative Therapies Group, 37.9% from Cardiac and Vascular Group and 29.1% from Minimally Invasive Therapies Group

    Medtronic revenue breakdown by geographic segment: 46.7% from Rest of World, 53.0% from United States and 0.3% from Other

    Human Capital Metrics

    Source: www.medtronic.com, www.medtronic.com
    Medtronic's employees are reported to be approximately 49% female and 51% male.
    Embed Graph
    Show all human capital metrics
    Report incorrect company information

    Competitors

    Olympus Corporation
    Manufacturing & Industrial - Public
    Nikkiso
    Manufacturing & Industrial - Public
    Boston Scientific
    Healthcare - Public
    Stryker
    Healthcare - Public
    St. Jude Medical
    Healthcare - Subsidiary
    Zimmer Biomet
    Healthcare - Public
    Compare competitors

    Medtronic Online and Social Media Presence

    Embed Graph
    Report incorrect company information

    Medtronic News and Updates

    January 17, 2019

    Global $2.9 Bn Hydroxyapatite Market to 2023: Investments by Major Players like Zimmer Biomet, Johnson & Johnson and Medtronic to Positively Influence the Market

    DUBLIN, Jan. 17, 2019 /PRNewswire/ -- The "Global Hydroxyapatite Market By Type (Nano-sized, Micro-sized and Greater than Micrometer), By Application (Orthopedic, Plastic Surgery, Dental Care and Others), By Region, Competition, Forecast & Opportunities, 2013-2023" report has been added...
    January 17, 2019

    Urology Surgical Instrument: Worldwide Market Outlook to 2024, Featuring Karl Storz, Olympus, Coloplast, Richard Wolf, Medtronic, and many more

    DUBLIN, Jan. 17, 2019 /PRNewswire/ -- The "Global Urology Surgical Instrument Market by Product, by Application - Size, Share, Development, Growth and Demand Forecast by 2018-2024" report has been added to ResearchAndMarkets.com's offering. Global Urology Surgical Instrument market report ...
    January 17, 2019

    Global Pressure Monitoring Devices Market Forecasts and Opportunities 2019: Key Players - Hill-Rom, Philips Healthcare, GE Healthcare, Medtronic, A&D Medical, Dragerwerk

    WiseGuyReports has added a new market intelligence report titled “Global Pressure Monitoring Devices Market Forecasts and Opportunities 2019: Key Players - Hill-Rom, Philips Healthcare, GE Healthcare, Medtronic, A&D Medical, Dragerwerk” to its storehouse of extensive and wide variety of reports.…
    January 17, 2019

    Explosive growth on Global Flash glucose monitoring system Market 2019 | Senseonics, Animas, Dexcom, Glysens, Medtronic, Omnipod, Roche, Ypsomed

    Flash glucose monitoring is the latest method of glucose testing, which appears to be a hybrid between the meter and the CGM. In Flash Glucose Monitoring, patients inserted the sensor into a separate touchscreen reader device. Posted via Industry Today. Follow us on Twitter @IndustryToday
    January 16, 2019

    Medtronic debuts first apps to let heart patients monitor their pacemakers

    In a world's first, a leading pacemaker manufacturer will enable patients to see the status of their heart implants using popular smartphones and tablets.
    January 16, 2019

    Neuromodulation Market 2023 report provides Latest improvements in the industry by anticipating the future perspective of the market, competitors, the top key players such as Medtronic plc, St. Jude Medical, Inc., LivaNova PLC

    The Global Neuromodulation Market is an analysis and portrayal of the market globally. It gives a clear image of the market and a thoughtful knowledge about its segments. The various sections are examined and is the key part of the Neuromodulation Market. Posted via Industry Today. Follow us on Twit…
    Show more
    Report incorrect company information

    Medtronic Company Life and Culture

    Report incorrect company information
    Download PDF

     Medtronic Frequently Asked Questions

    • When was Medtronic founded?

      Medtronic was founded in 1949.

    • Who are Medtronic key executives?

      Medtronic's key executives are Omar Ishrak, Karen Parkhill and Richard Kuntz.

    • How many employees does Medtronic have?

      Medtronic has 86,000 employees.

    • What is Medtronic revenue?

      Latest Medtronic annual revenue is $30 b.

    • What is Medtronic revenue per employee?

      Latest Medtronic revenue per employee is $348.3 k.

    • Who are Medtronic competitors?

      Competitors of Medtronic include Olympus Corporation, Nikkiso and Boston Scientific.

    • Where is Medtronic headquarters?

      Medtronic headquarters is located at 710 Medtronic Parkway, Minneapolis.

    • Where are Medtronic offices?

      Medtronic has offices in Minneapolis, Doral, Tempe, Tampa and in 83 other locations.

    • How many offices does Medtronic have?

      Medtronic has 95 offices.